Our multivariate analyses revealed that PIK3CA mutation in cervical cancer was an independent predictor for better RFS (HR = 0.54, 95% CI: 0.29–0.99, P = 0.048) (Table 3). This evidence concerns the gene PIK3CA and cervical cancer.